Movano (NASDAQ:MOVE) Issues Quarterly Earnings Results

Movano (NASDAQ:MOVE) announced its quarterly earnings data on Tuesday. The technology company reported ($3.13) EPS for the quarter, missing the consensus estimate of ($2.65) by ($0.48), FiscalAI reports. The firm had revenue of $0.51 million for the quarter, compared to analysts’ expectations of $7.63 million. Movano had a negative net margin of 2,462.55% and a negative return on equity of 647.91%.

Movano Price Performance

MOVE opened at $23.89 on Thursday. The stock has a 50-day moving average price of $15.19 and a 200-day moving average price of $12.02. The firm has a market cap of $27.00 million, a PE ratio of -2.25 and a beta of 0.80. Movano has a 1 year low of $3.44 and a 1 year high of $25.90.

Key Stories Impacting Movano

Here are the key news stories impacting Movano this week:

• Negative Sentiment: Movano reported a wider-than-expected loss of $3.13 per share, missing analyst estimates by $0.48, which suggests the business is still struggling to control losses. Movano Stock Performance
• Negative Sentiment: Revenue came in at just $0.51 million versus expectations of $7.63 million, a sharp shortfall that points to weak commercial traction and may pressure the stock. Movano Stock Performance
• Negative Sentiment: The company also posted very weak profitability metrics, including a deeply negative net margin and return on equity, which can keep investors cautious even after a sharp run-up in the share price. Movano Stock Performance

Hedge Funds Weigh In On Movano

A hedge fund recently bought a new stake in Movano stock. Citadel Advisors LLC purchased a new position in Movano Inc. (NASDAQ:MOVE) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 49,262 shares of the technology company’s stock, valued at approximately $28,000. Citadel Advisors LLC owned about 5.94% of Movano at the end of the most recent reporting period. Hedge funds and other institutional investors own 16.64% of the company’s stock.

Wall Street Analyst Weigh In

MOVE has been the subject of several recent research reports. Weiss Ratings reissued a “sell (e+)” rating on shares of Movano in a research report on Thursday, January 22nd. Wall Street Zen lowered Movano from a “hold” rating to a “sell” rating in a research report on Saturday, May 16th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Movano has a consensus rating of “Sell”.

About Movano

Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.